Article
- Author:
- Daniel M. Keller, PhD
Publish date: December 1, 2023
“What an absolute pleasure to be a mitral surgeon at a meeting where you’re presenting a solution for something that we find incredibly challenging...
News
- Author:
- Daniel M. Keller, PhD
Publish date: November 8, 2023
“This study provides evidence that stopping aspirin within 1 month after implantation of drug-eluting stents for ticagrelor monotherapy is a reason...
News
- Author:
- Daniel M. Keller, PhD
Publish date: November 6, 2023
This device is a U.S. FDA–designated breakthrough device, “and this pivotal trial will be the primary evidence used to support FDA approval.”
News
- Author:
- Daniel M. Keller, PhD
Publish date: October 31, 2023
“If this technology is approved by the FDA, it will provide a new option for our patients with very difficult-to-treat disease, which will provide ...
News
- Author:
- Daniel M. Keller, PhD
Publish date: October 30, 2023
One-year mortality rate of 7.8% reported.
News
- Author:
- Daniel M. Keller, PhD
Publish date: May 10, 2023
Nonsustained ventricular tachycardia, an important arrhythmia used every day in clinical practice to make decisions, is “much, much more prevalent ...
News
- Author:
- Daniel M. Keller, PhD
Publish date: May 4, 2023
Initiation of statins soon after diagnosis of AFib is associated with lower risk of ischemic and hemorrhagic strokes; longer-term use is tied to fu...
News
- Author:
- Daniel M. Keller, PhD
Publish date: October 13, 2021
The novelty of the new treatment approach is the duration of therapy as well as the dual antiglutamate drugs.
News
- Author:
- Daniel M. Keller, PhD
Publish date: October 13, 2021
Positive findings from genetic testing helped guide clinical management in 50% of cases and improved patient outcomes in 75%.
News
- Author:
- Daniel M. Keller, PhD
Publish date: October 7, 2021
A critical anatomical variation is still unrecognized by most clinicians performing botulinum toxin injections for oromandibular dystonia.
News
- Author:
- Daniel M. Keller, PhD
Publish date: September 30, 2021
About half of the study participants with Parkinson’s disease who developed post–COVID-19 syndrome experienced worsening motor symptoms and needed ...
News
- Author:
- Daniel M. Keller, PhD
Publish date: September 28, 2021
Patients receiving the drug saw significant reduction in upper-limb tremors, but adverse events led many to discontinue treatment.
News
- Author:
- Daniel M. Keller, PhD
Publish date: September 27, 2021
Study results show clear differences in a finger-tapping task in the Parkinson’s disease versus control group.
News
- Author:
- Daniel M. Keller, PhD
Publish date: September 22, 2021
“All patients, including those with organic tic disorders, had a history of anxiety and also reported worsening anxiety in the setting of the COVID...
News
- Author:
- Daniel M. Keller, PhD
Publish date: September 21, 2021
While using the sublingual apomorphine film, the majority of patients did not have dose-limiting nausea or vomiting.
